课题基金 / 基金详情

PHASE I/II TRIAL OF RECOMBINANT INTERLEUKIN 2 IN SYMPTOMATIC HIV INFECTED CHILD

PHASE I/II TRIAL OF RECOMBINANT INTERLEUKIN 2 IN SYMPTOMATIC HIV INFECTED CHILD
在有症状的 HIV 感染儿童中进行重组白细胞介素 2 的 I/II 期试验
批准号:
6276224
负责人:
ELIZABETH G MCFARLAND
金额:
$1.86万
依托单位国家:
美国
项目类别:
财政年份:
1997
资助国家:
美国
项目状态:
已结题
起止时间:
1997-12-01 至 1998-11-30

项目摘要

项目成果

ELIZABETH G MCFARLAND的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
This multicenter phase I/II open label study is to be performed in two stages sponsored by the ACTG. Part A will determine the maximally tolerated dose of rIL-2. Part B will treat 15 subjects with the MTD for 5 days every 8 weeks for 3 cycles. The primary objective is to determine the safety of rIL-2 when given to a larger number of children. Secondary objectives are to determine the effects of CD4 cell counts, viral load, and other immumnologic markers.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
ACTG 219--PEDIATRIC HIV LATE OUTCOMES PROTOCOL
  • 批准号:
    6114937
  • 项目类别:
  • 资助金额:
    $1.99万
  • 财政年份:
    1998
  • 负责人:
    ELIZABETH G MCFARLAND
  • 依托单位:
PHASE I/II TRIAL OF RECOMBINANT INTERLEUKIN 2 IN SYMPTOMATIC HIV INFECTED CHILD
  • 批准号:
    6114989
  • 项目类别:
  • 资助金额:
    $1.99万
  • 财政年份:
    1998
  • 负责人:
    ELIZABETH G MCFARLAND
  • 依托单位:
ACTG 273: HIVIG IN SLOWING DISEASE PROGRESSION IN HIV INFECTED CHILD
  • 批准号:
    6264279
  • 项目类别:
  • 资助金额:
    $1.99万
  • 财政年份:
    1998
  • 负责人:
    ELIZABETH G MCFARLAND
  • 依托单位:
ACTG 366: NOVEL ANTIRETROVIRAL THERAPY IN ANTIRETROVIRAL EXP CHILD
  • 批准号:
    6264294
  • 项目类别:
  • 资助金额:
    $1.99万
  • 财政年份:
    1998
  • 负责人:
    ELIZABETH G MCFARLAND
  • 依托单位:
海外基金